Theravance Biopharma (TBPH)
(Delayed Data from NSDQ)
$8.97 USD
-0.04 (-0.44%)
Updated Mar 28, 2024 03:59 PM ET
After-Market: $8.96 -0.01 (-0.11%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/13/2024
Time: -- |
3/2024 | $-0.19 | 0.00% |
Earnings Summary
For their last quarter, Theravance Biopharma (TBPH) reported earnings of $0.03 per share, beating the Zacks Consensus Estimate of $-0.04 per share. This reflects a positive earnings surprise of 175.00%. Look out for TBPH's next earnings release expected on May 13, 2024. For the next earning release, we expect the company to report earnings of -$0.19 per share, reflecting a year-over-year increase of 20.83%.
Earnings History
Price & Consensus
Zacks News for TBPH
Theravance's (TBPH) Q4 Earnings & Revenues Surpass Estimates
TBPH: What are Zacks experts saying now?
Zacks Private Portfolio Services